Acadia Pharmaceuticals is a startup based in the United States, 2 tracked investors.
Acadia Pharmaceuticals is a startup based in the United States. Brouky records 2 investors associated with the company.
Acadia Pharmaceuticals develops and commercializes novel therapies for neurological disorders and rare diseases, focusing on conditions such as Parkinson's Disease Psychosis, Rett Syndrome, and Alzheimer's Disease Psychosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.